Table 3.

Gene expression of IDO, CIITA and HLA-DR in MSCs of P2

MSC donors	2,3-IDO ng/µL	CIITA ng/µL	HLA-DR %
MSCs-310821-P2/PL-240	ND	46.9	6.9
MSCs-310821-P2/PL-240 + TGF-β1	ND	17.1	2.7
MSCs-310821-P2/PL-240 + IFN-γ	50.9	95.6	58.3
MSCs-310821-P2/PL-240 + IFN-γ + TGF-β1	35.1	67.3	40.1
MSCs-181116-P2/PL-269	ND	55.8	a6.3
MSCs-181116-P2/PL-269 + TGF-β1	ND	16.1	4.9
MSCs-181116-P2/PL-269 + IFN-γ	42.6	74.8	95.4
MSCs-181116-P2/PL-269 + IFN-γ + TGF-β1	36.9	64.5	93.4
MSCs-220922-P2/PL-269	1.4	55.2	29.5
MSCs-220922-P2/PL-269 + TGF-β1	ND	36.8	33.6
MSCs-220922-P2/PL-269 + IFN-γ	52.0	76.9	91.2
MSCs-220922-P2/PL-269 + IFN-γ + TGF-β1	42.9	62.5	90.3

^aMSCs of donor 181,116 after generation from BM-MNCs at P0 expressed high levels of HLA-DR, P0 = 31%

ND = not detected